Kintara Therapeutics Inc (KTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KTRA | BMY | AMGN | GILD | REGN |
| Company | Kintara Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1950 | 44.68 | 265.72 | 65.50 | 881.72 |
| High | 0.1950 | 45.37 | 271.68 | 66.35 | 887.48 |
| Low | 0.1464 | 44.34 | 265.72 | 64.63 | 875.23 |
| Last | 0.1452 | 45.21 | 269.92 | 65.84 | 879.28 |
| Change | -0.0128 | +0.51 | +0.54 | +0.57 | -11.40 |
| % Change | -8.10% | +1.14% | +0.20% | +0.87% | -1.28% |
| Volume | 45,029,712 | 6,595,843 | 420,571 | 5,366,756 | 162,299 |
| 20-Day Average Volume | 18,884,236 | 12,432,974 | 2,053,887 | 6,686,768 | 439,250 |
| Previous Close | 0.1580 | 44.70 | 269.38 | 65.27 | 890.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1263 | 49.49 | 269.97 | 68.30 | 918.53 |
| 20-Day Raw Stochastic | 42.85% | 8.39% | 38.53% | 10.48% | 8.21% |
| 20-Day Relative Strength | 57.98% | 30.87% | 45.08% | 29.85% | 33.05% |
| Weighted Alpha | -61.23 | -33.76 | +9.26 | -23.31 | +9.79 |
| Today's Opinion | 24% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Sell |
| Previous Opinion | 24% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 40% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.25% since 04/19/24 | -7.68% since 04/19/24 | +0.26% since 04/19/24 | -1.84% since 04/19/24 | -1.54% since 04/19/24 |
| Low | 0.1110 on 04/23/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 0.1950 on 04/26/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 915.70 on 04/24/24 |
| 1-Month | |||||
| %Chg | +73.39% since 03/26/24 | -14.04% since 03/26/24 | -4.31% since 03/26/24 | -9.50% since 03/26/24 | -8.36% since 03/26/24 |
| Low | 0.0860 on 03/27/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 0.2400 on 04/03/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +16.80% since 01/26/24 | -9.11% since 01/26/24 | -13.52% since 01/26/24 | -17.59% since 01/26/24 | -6.07% since 01/26/24 |
| Low | 0.0810 on 03/12/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 0.2400 on 04/03/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -96.21% since 10/26/23 | -14.73% since 10/26/23 | -0.03% since 10/26/23 | -16.52% since 10/26/23 | +11.49% since 10/26/23 |
| Low | 0.0810 on 03/12/24 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 769.19 on 10/27/23 |
| High | 4.3900 on 10/27/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,168 | 90,596,128 | 144,488,960 | 81,266,176 | 97,762,816 |
| Shares Outstanding, K | 39,038 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -14,650,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -1,020,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.57 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 02/14/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 24.12 |